News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
877,792 Results
Type
Article (88451)
Company Profile (813)
Press Release (788498)
Multimedia
Podcasts (222)
Webinars (34)
Section
Business (233446)
Career Advice (4155)
Deals (39930)
Drug Delivery (170)
Drug Development (91569)
Employer Resources (207)
FDA (18491)
Job Trends (17461)
News (398391)
Policy (40011)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3042)
Academic (2)
Accelerated approval (46)
Adcomms (37)
Allergies (179)
Alliances (56986)
ALS (211)
Alzheimer's disease (1901)
Antibody-drug conjugate (ADC) (463)
Approvals (18747)
Artificial intelligence (769)
Autoimmune disease (267)
Automation (57)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (227)
Biotechnology (486)
Bladder cancer (191)
Brain cancer (77)
Breast cancer (749)
Cancer (5890)
Cardiovascular disease (515)
Career advice (3585)
Career pathing (48)
CAR-T (341)
CDC (73)
Celiac Disease (2)
Cell therapy (937)
Cervical cancer (45)
Clinical research (78068)
Collaboration (2179)
Company closure (7)
Compensation (1356)
Complete response letters (96)
COVID-19 (3020)
CRISPR (112)
C-suite (1113)
Cystic fibrosis (161)
Data (7529)
Decentralized trials (3)
Denatured (83)
Depression (179)
Dermatology (72)
Diabetes (602)
Diagnostics (7456)
Digital health (60)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (382)
Drug pricing (239)
Drug shortages (39)
Duchenne muscular dystrophy (288)
Earnings (101425)
Editorial (74)
Employer branding (25)
Employer resources (174)
Events (136857)
Executive appointments (1131)
FDA (22180)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1785)
Gene editing (243)
Generative AI (85)
Gene therapy (767)
GLP-1 (1222)
Government (5523)
Grass and pollen (8)
Guidances (405)
Healthcare (21059)
HIV (84)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (333)
Immuno-oncology (97)
Indications (165)
Infectious disease (3386)
Inflammatory bowel disease (226)
Inflation Reduction Act (17)
Influenza (143)
Intellectual property (288)
Interviews (817)
IPO (17980)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (20)
Labor market (107)
Layoffs (672)
Leadership (46)
Legal (10169)
Liver cancer (106)
Longevity (31)
Lung cancer (785)
Lymphoma (424)
Machine learning (59)
Management (66)
Manufacturing (1062)
MASH (196)
Medical device (15178)
Medtech (15266)
Mergers & acquisitions (23157)
Metabolic disorders (1623)
mRNA (227)
Multiple sclerosis (188)
NASH (24)
Neurodegenerative disease (443)
Neuropsychiatric disorders (117)
Neuroscience (3473)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5131)
Now hiring (75)
Obesity (793)
Opinion (360)
Ovarian cancer (204)
Pain (262)
Pancreatic cancer (284)
Parkinson's disease (377)
Partnered (39)
Patents (596)
Patient recruitment (654)
Peanut (66)
People (67552)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24119)
Phase 2 (33893)
Phase 3 (25501)
Pipeline (7749)
Policy (378)
Postmarket research (3556)
Preclinical (10849)
Press Release (72)
Prostate cancer (299)
Psychedelics (62)
Radiopharmaceuticals (344)
Rare diseases (1137)
Real estate (7449)
Recruiting (81)
Regulatory (29818)
Reports (75)
Research institute (2759)
Resumes & cover letters (653)
Rett syndrome (35)
RNA editing (24)
RSV (98)
Schizophrenia (182)
Series A (297)
Series B (219)
Service/supplier (30)
Sickle cell disease (117)
Special edition (30)
Spinal muscular atrophy (186)
Sponsored (53)
Startups (4352)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (136)
Vaccines (1245)
Venture capital (114)
Weight loss (546)
Women's health (121)
Worklife (24)
Date
Today (213)
Last 7 days (792)
Last 30 days (2769)
Last 365 days (33132)
2026 (10123)
2025 (33227)
2024 (38126)
2023 (42567)
2022 (53929)
2021 (58723)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1293)
Alabama (100)
Alaska (7)
Arizona (378)
Arkansas (16)
Asia (51957)
Australia (9132)
California (13075)
Canada (3718)
China (1379)
Colorado (565)
Connecticut (579)
Delaware (398)
Europe (119660)
Florida (1948)
Georgia (428)
Hawaii (4)
Idaho (69)
Illinois (1125)
India (94)
Indiana (616)
Iowa (25)
Japan (529)
Kansas (138)
Kentucky (52)
Louisiana (44)
Maine (87)
Maryland (1608)
Massachusetts (9568)
Michigan (397)
Minnesota (738)
Mississippi (7)
Missouri (158)
Montana (37)
Nebraska (30)
Nevada (144)
New Hampshire (91)
New Jersey (3511)
New Mexico (33)
New York (3460)
North Carolina (1778)
North Dakota (10)
Northern California (6391)
Ohio (404)
Oklahoma (26)
Oregon (55)
Pennsylvania (2613)
Puerto Rico (29)
Rhode Island (53)
South America (1668)
South Carolina (84)
South Dakota (2)
Southern California (5106)
Tennessee (209)
Texas (2111)
United States (47048)
Utah (394)
Vermont (1)
Virginia (331)
Washington D.C. (88)
Washington State (1083)
West Virginia (4)
Wisconsin (147)
Wyoming (2)
There are 877,792 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nextleaf Advances Capex-Light Model with New Micro-Processing Site Licence, Supporting Revenue Growth and Margin Expansion
April 20, 2026
·
6 min read
Press Releases
Huxley Health Inc. Introduces Aerasyn Biotech Division, Expands Leadership and Scalable IP Platform, Engages Capital Partner for Up to $15M Financing and Prepares to Go Public Amid Growing U.S. Policy and Public Discourse on Psychedelics
April 20, 2026
·
8 min read
Press Releases
PharmaTher’s Microneedle Patch Platforms Positioned to Benefit from Major U.S. Catalysts in Psychedelics and Peptides
U.S. regulatory momentum in psychedelics and peptides could open new commercial opportunities for PharmaTher’s PatchPrint™ automated manufacturing platform and PharmaPatch™ product platform as an attractive solution for compounding pharmacies, hospitals, research institutions, and commercial partners
April 20, 2026
·
8 min read
Press Releases
Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products
The Company’s Health Canada-licensed GMP psychedelic manufacturing platform ready to serve emerging demand for ibogaine, a naturally occurring alkaloid under investigation for opioid use disorder, PTSD, and traumatic brain injury
April 20, 2026
·
6 min read
Press Releases
Sharp Therapeutics Corp. Announces Fourth Quarter 2025 Results, Closing of Convertible Note Offering and Adoption of Semi-Annual Reporting
April 20, 2026
·
7 min read
Press Releases
American Aires Provides Update on Liquidity Position, Strategic Review and Ongoing Litigation
April 20, 2026
·
4 min read
Press Releases
Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy
• Strong global consensus on measurement and role of ammonia in Hepatic Encephalopathy (HE) • Phase 2a results of YAQ007 (oral OPA) show ammonia reduction • Utility of rifaximin in HE defined more narrowly
April 20, 2026
·
1 min read
Press Releases
Integrated DNA Technologies Expands Coralville Manufacturing Footprint to Support Growing Global Demand for MRD Solutions
April 20, 2026
·
5 min read
Press Releases
Allurion Treats First Commercial Patients in the United States, Marking Major Milestone
April 20, 2026
·
4 min read
Press Releases
Following Oral Presentation of Phase I Data at AACR 2026, Debiopharm Announces FDA Fast Track Designation for Lunresertib in Combination With Zedoresertib for Genomic-Defined Platinum-Resistant Ovarian Cancer
April 20, 2026
·
3 min read
1 of 87,780
Next
